Daily Stock List
Senesco Technologies, Inc. (SNTI)
Today we are reporting on Senesco Technologies, Inc. (SNTI), here at the QualityStocks Daily Newsletter.
Senesco Technologies, Inc. is a leader in eIF5A technology. The basis of Senesco's platform technology is on the discovery that eIF5A (Factor 5A), a gene that is highly conserved from plants to people, can regulate programmed cell death (apoptosis) and cell survival through controlling the expression of pro-apoptotic and anti-apoptotic proteins. The Company is running a clinical study with their lead therapeutic candidate SNS01-T, which targets B-cell cancers by selectively inducing apoptosis by modulating eukaryotic, translation, initiation Factor 5A (eIF5A). Senesco Technologies is based in Bridgewater, New Jersey.
Senesco has already collaborated with top companies engaged in agricultural biotechnology and biofuels development. The Company is entitled to earn research and development milestones and royalties if their gene-regulating platform technology is incorporated into their partners' products.
Concerning Therapeutics, Senesco's present focus is on cancer - specifically on multiple myeloma (MM) and other B-cell cancers including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL). SNS01-T has been shown to inhibit the growth and even shrink tumors in animal models of human B-cell cancers. This includes multiple myeloma, mantle cell lymphomia and diffuse large b-cell lymphoma. SNS01-T has been granted orphan drug status by the US FDA.
Yesterday, Senesco Technologies reported that they completed cohort 2 in their Phase 1b/2a clinical study of SNS01-T. Senesco is the sponsor of the Phase 1b/2a study. In cohort 2, two multiple myeloma patients and one diffuse large B-cell lymphoma patient have completed the study. The safety data for the group will be provided to the Data Review Committee (DRC). The DRC will meet and advise Senesco Technologies whether it is appropriate to proceed with cohort 3 and escalate the dose level to 0.2 mg/kg, a four-fold increase.
Leslie J. Browne, Ph.D., President and Chief Executive Officer of Senesco Technologies, stated, "We are pleased to have completed the second cohort in our Phase 1b/2a study. As soon as the DRC gives the go ahead, we expect to initiate cohort 3 and increase the dose level to 0.2 mg/kg."
Senesco Technologies, Inc. (SNTI), closed Tuesday's trading session at $0.075, up 25.00%, on 1,866,660 volume with 61 trades. The average volume for the last 60 days is 451,428 and the stock's 52-week low/high is $0.055/$0.20.
Colossus Minerals, Inc. (COLUF)
Streetwise Reports reported earlier on Colossus Minerals, Inc. (COLUF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Toronto, Ontario, Colossus Minerals, Inc. is an exploration and development company that lists on the OTC Markets' OTCQX. The Company's principal focus is to advance the Serra Pelada project, located in Para, Brazil, into production. Brazil has many world-class deposits of gold, iron ore, copper, nickel, manganese and bauxite spread through their extensive and diverse geological terrains. Serra Pelada is host to one of the highest-grade gold and platinum group metal deposits in the world.
Serra Pelada is in the mineral prolific Carajas region near the towns of Curionopolis and Parauapebas, Para State, northern Brazil. Here, the access and infrastructure are first-rate. Serra Pelada hosted the largest ever gold rush in Latin America. During the 1980s, up to 80,000 artisanal miners produced an estimated 2 million ounces of gold and platinum and palladium, from a 400m x 300m x 100m hand dug open pit.
In July 2007, Colossus Minerals and Coomigasp (a registered Brazilian cooperative company) formed a partnership to develop the remaining bedrock mineralization at Serra Pelada. Colossus will manage and operate the project, earning a majority interest by funding exploration and paying Coomigasp a premium for the gold reserve established by the joint venture. In March 2010, Colossus Minerals successfully acquired 774 Hectares of additional ground contiguous to Serra Pelada. The ownership structure of the total land package remains 75 percent to the Company and 25 percent to Coomigasp.
Colossus Minerals remains on course to begin first production early in the second half of this year at an initial rate of 250 tonnes per day (tpd). They will continue the ramp up phase throughout the rest of 2013 to 500 tpd. The current plan sees two active mining faces for 250 tpd of production, three to five mining faces for 500 tpd of production, as well as six to nine mining faces for 1,000 tpd of production. They expect to achieve 1,000 tpd of production by the end of the first quarter of 2014.
Colossus Minerals, Inc. (COLUF), closed Tuesday's trading session at $2.09, down 0.99%, on 23,090 volume with 54 trades. The average volume for the last 60 days is 50,062 and the stock's 52-week low/high is $1.73/$6.1274.
Destiny Media Technologies, Inc. (DSNY)
Greenbackers, SmallCapVoice, Bullseyestox.com, Blaque Capital Stocks, Breaking Bulls, Stockhouse, and OTC Picks reported previously on Destiny Media Technologies, Inc. (DSNY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Destiny Media Technologies, Inc. is a leading provider of secure digital content distribution solutions. This includes audio and video streaming solutions and secure file distribution to customers around the world. Patents include watermarking, peer-to-peer locking, and pending cross platform playerless streaming video. The Company has developed two broad product lines - MPE® and Clipstream®.
MPE® enables the secure download of audio or video to a user's computer. Content can be locked to a recipient computer marked with a digital watermark that identifies copies. Destiny Media's largest and fastest growing product in the MPE® line is Play MPE®. The recording industry uses the Play MPE® system to distribute new pre-release music securely through the internet to trusted recipients. These recipients include radio, media, and VIP's.
The Company's Clipstream® enables users to stream internet audio and video directly inside an email or web page. The basis of the system is the Java applet. The content will play directly within the email or web page rather than in a separate window; it will instantly play for 98 percent of the internet audience without the download of additional application software.
Destiny Media has developed a suite of four distinct software products, which incorporate their Clipstream® technology. They market these under their Clipstream® brand name. These are Clipstream® Audio, Clipstream® Video, Clipstream® Live, and Clipstream® Audiomail.
The current generation of Clipstream® doesn't require a streaming server. It caches, therefore it saves 90 percent on bandwidth costs for popular content. It does this while providing a higher quality of service because of the better scalability. This next generation is completely cross platform to all recent devices and operating systems, including those that don't support Java.
Last week, Destiny Media Technologies announced a key upgrade to the software and hardware infrastructure that powers the Play MPE® Direct-to-Web portal (http://goplay.plaympe.com). Tens of thousands of music industry professionals use this website to access pre-release music and videos distributed through the Play MPE® system. The upgrade expands access to include HTML 5 and legacy browsers on all modern computers, smart phones, tablets as well as other devices.
Destiny Media Technologies, Inc. (DSNY), closed Tuesday's trading session at $0.81, up 0.62%, on 123,113 volume with 39 trades. The average volume for the last 60 days is 66,627 and the stock's 52-week low/high is $0.57/$1.06.
Echo Automotive, Inc. (ECAU)
PennyStocks24, Paragon Financial Report, and Penny Stocks VIP reported recently on Echo Automotive, Inc. (ECAU), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Echo Automotive, Inc. is a developer of technologies and products that allow for the cost effective conversion of existing vehicles into highly fuel-efficient hybrids and plug-in hybrids. The key to the Company's strategy is the bolt-on nature of their solution that introduces little or, in some cases, almost no additional points of failure. Echo Automotive is based in Anderson, Indiana. The Company also has an office in Scottsdale, Arizona. Echo Automotive lists on the OTC Bulletin Board.
The basis of Echo Automotive's business plan is on providing the marketplace a business proposition for reducing the use of fossil fuels by augmenting power trains within existing commercial fleet vehicles with highly efficient electrical assistance delivered via electric motors powered by the Company's modular plug-in battery modules. This is to achieve fast real world operating results. This includes a quick return on the investment (of the Echo conversion) for such amended vehicles.
Echo Automotive's EchoDrive is an innovative cost-reduction platform for converting fleet vehicles into highly fuel-efficient plug-in hybrids. EchoDrive can be easily bolted onto new and existing vehicles cost-effectively, for significantly reducing a fleet vehicle's operating cost.
Recently, Echo Automotive announced the signing of an agreement with Meineke Car Care Centers, Inc. to serve as a national service center and installer for Echo Automotive™ systems. Echo Automotive is concentrating on the importance of having key vendor relationships as part of the Company's business plan. There exist approximately 900 Meineke franchises throughout the U.S., Canada, Mexico, Brazil, China, Saudi Arabia and the Caribbean. Meineke franchisees have serviced more than 50,000,000 vehicles since 1972.
Earlier this month, Echo Automotive announced the execution of a voluntary Exchange Agreement with Advanced Technical Asset Holdings (ATAH) through the issuance and filing of a form 8-K with the Securities and Exchange Commission (SEC) regarding this major event. The voluntary exchange between the two companies transfers to Echo Automotive the ATAH assets and intellectual property that were acquired by ATAH from Bright Automotive.
Echo Automotive, Inc. (ECAU), closed Tuesday's trading session at $0.526, down 0.75%, on 46,983 volume with 48 trades. The average volume for the last 60 days is 1,494,033 and the stock's 52-week low/high is $3.61/$0.2811.
Guided Therapeutics, Inc. (GTHP)
PennyTrader Publisher, Pennystocktweeters.cor, NYC Marketing Inc, AllPennyStocks, and Momentum Trades reported previously on Guided Therapeutics, Inc. (GTHP), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Norcross, Georgia, Guided Therapeutics, Inc. is developing a rapid and painless testing platform. This platform is for the early detection of disease based on the Company's patented biophotonic technology that uses light to detect disease at the cellular level. The Company's first planned product is the LuViva® Advanced Cervical Scan - a non-invasive device used to detect cervical disease instantly and at the point of care.
The aforementioned Biophotonics is the science of generating and harnessing light to image, detect and manipulate biological materials. In a multi-center clinical trial, with women at risk for cervical disease, the LuViva® Advanced Cervical Scan technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports.
The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use. The LuViva Advanced Cervical Scan is now compliant with both Edition 2 and Edition 3 CE standards. It has marketing approval from Health Canada and the Singapore Health Sciences Authority, and it is under U.S. Food and Drug Administration (FDA) Premarket review.
The design of LuViva® is as a fast, painless test that, unlike Pap smears and HPV testing, does not require a tissue sample or the delay of laboratory analysis. LuViva® utilizes proprietary technology to identify cancers and precancers quickly by analyzing light reflected from the cervix. The technology distinguishes between normal and diseased tissue by detecting biochemical and morphological changes at the cellular level.
Guided Therapeutics is also developing a non-invasive test for the early detection of esophageal cancer using the technology platform. This is the Esophageal Dysplasia Detection System, or EDDS. EDDS is a non-invasive, point of care device that uses biophotonics to scan the surface of the esophagus known as the "Barrett's Esophagus" area.
Last week, the Company announced that they shipped their first Edition 3 CE marked LuViva® Advanced Cervical Scan unit to their distributor in Turkey. The delivery is the first of 15 to 20 units that the Company expects to ship to distributors in the second quarter.
Guided Therapeutics, Inc. (GTHP), closed Tuesday's trading session at $0.90, up 6.01%, on 127,963 volume with 46 trades. The average volume for the last 60 days is 52,086 and the stock's 52-week low/high is $0.462/$0.96.
Endeavour Mining Corp. (EDVMF)
We are highlighting Endeavour Mining Corp. (EDVMF), here at the QualityStocks Daily Newsletter.
Headquartered in Los Angeles, California, Sunvalley Solar, Inc. is a solar power technology and system integration enterprise. The Company offers complete solar energy technology, system design, installation, equipments, and technical support. They offer these for electrical contractors, builders, homeowners, businesses and commercial buildings, as well as government entities. The Company provides an all-in-one service for customers' solar system needs - from system design and permitting, to installation and final inspection. Sunvalley Solar lists on the OTC Markets' OTCQB.
The Company is a leading solar electric equipment wholesale distributor for solar photovoltaic equipment of manufacturers including CEEG-SST and Canadian Solar, Inc., in addition to PV Powered and SMA Sunny Boy Inverters, and ProSolar for racking system products. Sunvalley Solar specializes in packaged solar system solutions. At present, they distribute to over 600 clients in more than 21 states. They provide solar equipment as well as technical support.
Sunvalley Solar has designed and installed more than two million watts of solar power systems. Their experience includes residential, small commercial, and complex large commercial solar system integration projects. The projects include 975kW commercial solar power systems for distribution warehouses and manufacturing companies, as well as 1MW commercial solar power systems for agriculture farms and cold storage facilities.
Last week, Sunvalley Solar announced that they were awarded a new 129.5 KW solar system installation contract from Amerifreight, Inc in City of Industry, California. The contract is for a system that can generate 190,688 kWh of electrical power each year. The system uses 518 pieces of high efficiency 250-watt Polycrystalline solar panels. The project installation will start by the middle of this year.
Mr. James Zhang, Chief Executive Officer of Sunvalley Solar, said last week, "This is our second solar energy system installation contract for Amerifreight in 2013 at their facility in City of Industry. Our commitment to quality and total customer satisfaction is evident in the award of this second installation contract. Our work speaks for itself and we look forward to helping more commercial owners achieve the best energy solutions while making a positive environmental impact."
Endeavour Mining Corp. (EDVMF), closed Tuesday's trading session at $0.8898, down 0.02%, on 8,500 volume with 4 trades. The average volume for the last 60 days is 91,677 and the stock's 52-week low/high is $0.823/$2.6034.
International Tower Hill Mines Ltd. (THM)
PennyStocks24, PremiereStockAlerts, Fast Moving Stocks, Mega Penny Stock Pick, HotShotStocks, SmartTrend Newsletters, OtcWizard, and The Street reported earlier on International Tower Hill Mines Ltd. (THM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Based in Vancouver, British Columbia, International Tower Hill Mines Ltd. involves in the acquisition, exploration, evaluation, and development of mineral properties. The Company controls a 100 percent interest in the world-class Livengood Gold Project in the State of Alaska. This Project is accessible by paved highway 70 miles north of Fairbanks. The Livengood Gold Project has a resource size of 16.5 million ounces in the Measured & Indicated categories plus 4.1 million ounces in the Inferred category.
A staff with major mining company expertise from AngloGold,
Gold Fields, Newmont, Teck and Kinross, with proven records of accomplishment in project permitting and development, lead International Tower Hill Mines. The Company purchased the Livengood claims from AngloGold Ashanti in 2006. Since 1914, there has been placer mining in the Livengood region.
The Livengood gold resource has expanded significantly since being discovered in late 2006 with aggressive resource expansion drilling programs that presently total more than 650,000 feet in more than 800 drill holes. The current resource covers only one square mile of the Company's 78 square mile land package. In addition, gold mineralization has been discovered outside the Livengood deposit from 2009 to 2011. This represents major resource expansion potential.
In March, International Tower Hill Mines reported that they are concentrating on completing all the engineering and analysis to support the completion of their Feasibility Study and the environmental work needed to maintain their current schedule. The Company additionally reported that the Livengood Feasibility/Optimization Study is on schedule and on budget. The mine design/production schedule alternatives have been completed; this includes equipment specifications and bids.
Metallurgical tests to optimize recovery have been completed, the milling process design circuit has been completed, and throughput optimization is now undergoing assessment. The mill will include an initial gravity circuit followed by standard carbon in leach recovery circuit (CIL) akin to the process used at the Fort Knox mine, 45 air miles to the southeast. Environmental baseline information collection has entered its fifth year, establishing vital benchmarks for mine permitting needs.
International Tower Hill Mines Ltd. (THM), closed Tuesday's trading session at $0.97, even for the day, on 196,409 volume with 658 trades. The average volume for the last 60 days is 229,177 and the stock's 52-week low/high is $0.913/$4.16.
Aethlon Medical, Inc. (AEMD)
Investor Ideas, FeedBlitz, and PennyStocks24 reported on Aethlon Medical, Inc. (AEMD), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Aethlon Medical, Inc.'s corporate mission is to create novel medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Their Aethlon ADAPT™ System (Adaptive Dialysis-Like Affinity Platform Technology) is a revenue-stage technology platform. This system provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. Aethlon Medical's shares trade on the OTC Bulletin Board.
The Aethlon ADAPT™ System is a medical device platform that converges single or multiple affinity drug agents with advanced plasma membrane technology to create therapeutic filtration devices that selectively remove harmful particles from the entire circulatory system without loss of essential blood components. Currently, the Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device undergoing development under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.
The Company's Aethlon Hemopurifier® is a first-in-class medical device with broad-spectrum capabilities against viral pathogens. These include the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and many bioterror and pandemic threats.
Aethlon Medical also has their HER2osome™. It provides a therapeutic strategy to maximize the ability of the immune system and established drug therapies to combat HER2+ breast cancer. In addition, the Company has their ELLSA™ Exosome Assay. This is an enzyme-linked lectin-specific assay that has demonstrated the ability to identify and quantify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and all forms of cancer tested to date.
Last week, Aethlon Medical announced that the Company entered into a subcontract agreement with Battelle Memorial Institute to provide services underlying a $22.8 million prime contract that was recently awarded to Battelle by the Defense Advanced Research Projects Agency (DARPA). The goal of this contract program is to integrate component technologies developed in DARPA's Dialysis Like Therapeutics (DLT) program into medical devices that would save military and civilian lives by effectively treating sepsis.
Furthermore, Aethlon reported last week that they resubmitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) on March 25, 2013. The Company's objective is to receive permission to commence a clinical feasibility study of Hepatitis-C (HCV) infected individuals who would be enrolled to receive Hemopurifier® therapy.
Aethlon Medical, Inc. (AEMD), closed Tuesday's trading session at $0.12, up 14.29%, on 486,530 volume with 31 trades. The average volume for the last 60 days is 319,476 and the stock's 52-week low/high is $0.06/$0.15.
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.095, up 13.10%, on 124,759 volume with 32 trades. The stock’s average daily volume over the past 60 days is 74,203, and its 52-week low/high is $0.0322/$4.88.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
DoMark Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
DoMark International Announces the Signing of an M.O.U. to Purchase Game Changing New Samsung and Apple Accessory Product Developer Zaktek Ltd.
Apple and Samsung Accessory Leader: DoMark Announces the Finalization of Its Restructure
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.10, up 5.26%, on 80,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 27,256, and its 52-week low/high is $0.073/$0.1721.
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
VentriPoint Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
VentriPoint Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
VentriPoint Announces $2 Million Unit Private Placement
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.26, up 3.59%, on 56,446 volume with 23 trades. The stock’s average daily volume over the past 60 days is 183,939, and its 52-week low/high is $0.161/$0.55.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Fourth Quarter 2012 Financial Results and Provides Business Update
International Stem Cell Corp. to Host Conference Call Thursday, March 28 to Discuss Year End 2012 Financial Results and Provide Business Update
International Stem Cell Corp. to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.015, up 2.04%, on 585,000 volume with 14 trades. The stock’s average daily volume over the past 60 days is 806,911, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
VIASPACE Insiders Extend Lock-up of Shares
VIASPACE Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
If you look at a map of the U.S. that is shaded according to the percentage of housing units that are in foreclosure, the focal points of the county’s recent real estate meltdown can still be seen. Nevada continues to lead the list, as it did during the heart of the crisis, while Florida, always near the top, now ranks second. But California, once running close to Nevada, has recently improved significantly. In fact, California is now experiencing what some are calling the beginning of a real estate boom.
A few years ago, California was considered one of the ground-zero states in terms of foreclosure activity, with California and a few other hard hit states accounting for more than half of all foreclosures in the nation. Some California cities, like Merced, had foreclosure rates topping 10%. In 2009, a record 600,000 homes in California received a foreclosure filing, the greatest number of any state.
Today the California real estate headlines are all about shrinking inventory and rising prices. The number of foreclosure sales in California has dropped to nearly half of what it used to be, while sales prices have increased every month for the past year. Most recently, median sales prices in California are reported to have jumped by over 8% in March alone.
California-based Loans4Less.com, an expanding online mortgage loan brokerage, finds itself in a perfect position to take advantage of this rapidly rising sea. However, unlike the previous real estate bubble, where mortgages were nearly handed out like candy at a state fair, today’s mortgage market is far stricter. It’s a new-found respect for the principles of sound underwriting that fits neatly with the Loans4Less philosophy of focusing on “A” paper residential loans. The company was recently ranked by Origination News as one of the top 2012 loan producers by dollar volume, and they are actively seeking to use partnerships and online technology to expand their successful business model across the country.
For more information, visit www.Loans4Less.com
A market leader in disk-based data protection, FalconStor Software proclaimed that Robert Zecha is to join its team as executive vice president and chief product officer. Zecha will oversee program management, product management, product development, and quality assurance.
Zecha will execute product strategy, as well as oversee FalconStor’s suite of data protection products. With extensive engineering and business management experience, Zecha will drive new solutions to resolve growing industry data protection issues.
President and CEO of FalconStor, Jim McNiel stated, “The new position of chief product officer demonstrates our commitment to designing and bringing to market original solutions that solve today’s complex data protection challenges.” McNiel continued, “with his entrepreneurial spirit, executive business leadership and a proven ability to execute, Rob will further our mission to develop innovative technology and promote new best practices that will ensure FalconStor’s position as the industry’s most trusted data protection partner.”
Previously Zecha held the role of vice president of engineering and operations for Altior. He has also held the positions of vice president of business development, engineering, and marketing at SMSC and vice president of engineering as founder of Afide. Additionally Zecha founded and led NetVision Corporation to a successful acquisition by Network Peripherals. Robert Zecha is currently a member of the Institute of Electrical and Electronics Engineers.
“Today’s storage and data protection market is undergoing a major shift as legacy solutions prove inadequate in the face of unabated data growth, broad adoption of virtualization, cloud-based services and Big Data,” comments Zecha. “In addition, recent events have turned a spotlight on the need for continuous business operations and automated disaster recovery solutions that will eliminate costly downtime. Organizations need to migrate to new ways of managing and protecting critical business information and IT services – and FalconStor is uniquely qualified to meet that need and take advantage of a huge market opportunity.”
For more information, please visit www.falconstor.com
Quantum Fuel Systems Technologies Worldwide, a leader in natural gas storage systems, integration, and vehicle system technologies, announced today that its proposal in response to the Program Opportunity Notice entitled “Advanced Natural Gas Engine Research and Development for Class 3 through Class 7 Applications” has received a notification of recommendation for a $1 million grant award from the California Energy Commission’s (CEC) Public Interest Energy Research Program. In addition, Southern California Gas has also dedicated supplementary funding to assist the project in meeting its technical benchmarks.
Specifically, the grant will fund the development and validation of a multi-port fuel injected natural-gas fuel system and engine with cutting edge controls that can be fabricated at a low price point, for use in Class 3 to Class 7 fleet applications such as buses, medium-duty trucks, and port freight-handling vehicles. Power Solutions International, Inc. (PSI) will be partnering with Quantum on this forward thinking project. PSI is a prominent cleantech engine manufacturer. Quantum will also partner with technology and strategy consultancy, Ricardo, and the University of California, Riverside. PSI’s new 8.8-liter engine will serve as the base engine for the project, which is targeting a 20% improvement in fuel economy, as well as a 16% gain in power density for the natural gas version. Achieving these goals will serve to meet an urgent market demand for advanced natural gas options for medium duty applications.
“We are excited and honored to have been selected by the California Energy Commission and to be working with PSI and Ricardo, proven leaders in their respective fields,” said Brian Olson , CEO and President of Quantum. “We are pleased to leverage our decades of experience in developing natural gas fuel systems and fill a need in the industry that is in short supply of natural gas engines for the high growth medium duty market segment.”
“We thank CEC for funding the development of clean-energy answers to America’s transportation issues,” said Gary Winemaster, CEO of PSI. “This project addresses the number one market barrier for natural-gas vehicles—the high price differential of natural-gas engines, by offering fleet owners a lighter, more efficient 8-liter class option at a lower cost than anything commercially available today.”
For further information, please visit www.qtww.com
Leading cloud payment processing solutions provider US Dataworks has announced a partnership with Revo Payments to expand US Dataworks’ Clearingworks cloud lockbox solution to include electronic invoicing. The combined product will deliver an end-to-end e-invoicing and payment solution utilizing private cloud technologies – making it easy for businesses of all sizes to implement the solution.
Now, banks can serve their middle market customers with the advanced electronic lockbox technology and receivables automation that were previously available only to large corporations using highly customized solutions. Clearingworks additionally images all paper invoices, remittance documents, and checks for a total invoicing and receivables solution.
“Revo Payments brings the same level of innovation and simplicity to the e-invoicing process that Clearingworks brings to lockbox and consolidated receivables processing,” said Marc Palombo, senior vice president of sales and channel partners for US Dataworks. “Our partnership lays the foundation for the next generation in lockbox and receivables processing and will provide banks with a powerful strategic selling tool for acquiring new customers.”
Though most businesses desire to move to processing that is fully electronic, in reality, almost 70% of all business-to-business payments are still made through the old-fashioned methods of printing invoices and mailing checks. This combined solution from US Dataworks and Revo breaks down barriers to achieving fully electronic invoice presentment and payments.
The combined solution from US Dataworks and Revo will be provided as a cloud-based treasury management service that is delivered chiefly through financial institutions. It is anticipated that banks will utilize the solution as an attraction for new customers and to create stronger relationships with existing customers. The benefits of the solution include: expedited and simplified cash application, ability to accept all payment types from all payment channels, dashboards that are tailored to the user, industry segment configurations, consolidated reporting of all receivables, simple implementation, and simple to support.
The solution will be showcased in US Dataworks booth No. 705 and in the Payments 3-D Pavilion at Payments 2013, which is an annual conference of the National Automated Clearing House Association.
For more information, visit www.usdataworks.com or www.revopayments.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) and FusionVax Sign a Memorandum of Understanding for the License of Advaxis’ ADXS-HPV in Asia
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- DoMark International, Inc. (DOMK) Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Nears Deal With Leading Genetic Testing Lab
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Aristocrat Group Corp. (ASCC) Leadership Travels to Las Vegas to Discuss Launch Opportunities for New Vodka
- The Guitammer Company Inc. (GTMM) Joins D-Tools Manufacturer Vantage Point (MVP) Program
- VentriPoint Diagnostics Ltd. (VPTDF) Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
- Viaspace, Inc. (VSPC) and AGRICORP Partnership on Giant King Grass in Nicaragua: 12MW Biomass Power Plant Targeted
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement